Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
"Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial." Eli Lilly and Company , 11 Dec
Aim for 1.2 to 1.6 grams per kilogram of body weight per day
American Journal of Physiology Endocrinology and Metabolism, 282(2), E474E482
Maximise ResultsTurn Your Fat into Fuel
This improves energy levels and reduces fatigue
The effects of ER once-weekly have been compared to exenatide twice-daily and overall ER was more effective at improving glycemic control and caused less gastrointestinal side-effects although both compounds caused a similar degree of weight loss (Drucker et al., The efficacy of once-weekly ER (2 mg) was compared to that of once-daily liraglutide (1.8 mg) in a 26-week trial in T2DM patients (Buse et al., DPP-4 inhibitors The DPP-4 inhibitors mediate their action by inhibiting the enzyme DPP-4, which prevents the breakdown of GLP-1 and thereby increases endogenous GLP-1 levels
US$ 21.86
US$ 23.83
US$ 23.89
US$ 22.87
US$ 25.19
US$ 20.21
US$ 27.95
US$ 26.96
